As of close of business last night, HIVE Blockchain Technologies Ltd.’s stock clocked out at $3.07, down -2.85% from its previous closing price of $3.16. In other words, the price has decreased by -$0.0900 from its previous closing price. On the day, 658800 shares were traded. HIVE stock price reached its highest trading level at $3.2607 during the session, while it also had its lowest trading level at $3.0213.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
To gain a deeper understanding of HIVE’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.93 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.94. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 2.90. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIVE now has a Market Capitalization of 313.86M and an Enterprise Value of 336.69M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.87 while its Price-to-Book (P/B) ratio in mrq is 1.33. Its current Enterprise Value per Revenue stands at 2.44 whereas that against EBITDA is -2.32.
Stock Price History:
Over the past 52 weeks, HIVE has reached a high of $7.53, while it has fallen to a 52-week low of $1.36. The 50-Day Moving Average of the stock is 3.2218, while the 200-Day Moving Average is calculated to be 3.2777.
It appears that HIVE traded 1.14M shares on average per day over the past three months and 758.27k shares per day over the past ten days. A total of 115.06M shares are outstanding, with a floating share count of 83.47M. Insiders hold about 0.16% of the company’s shares, while institutions hold 16.24% stake in the company. Shares short for HIVE as of Apr 27, 2023 were 5.6M with a Short Ratio of 5.60M, compared to 6.24M on Mar 30, 2023.
As of right now, 2 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.28 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$2.95 and -$2.98 for the fiscal current year, implying an average EPS of -$2.96. EPS for the following year is -$0.68, with 2 analysts recommending between -$0.18 and -$1.19.
A total of 3 analysts have provided revenue estimates for HIVE’s current fiscal year. The highest revenue estimate was $106.4M, while the lowest revenue estimate was $104.7M, resulting in an average revenue estimate of $105.37M. In the same quarter a year ago, actual revenue was $209.61M, down -49.70% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $97.45M in the next fiscal year. The high estimate is $99.6M and the low estimate is $95.3M. The average revenue growth estimate for next year is down -7.50% from the average revenue estimate for this year.